Shock or no shock-a question of philosophy or should intraoperative implantable cardioverter defibrillator testing be recommended?

Interactive Cardiovascular and Thoracic Surgery

Volumn 16, Issue 3, 2013, Pages 321-325

  Keyser, Andreas ^a   Hilker, Michael K ^a   Schmidt, Sebastian ^a   Von Bary, Christian ^a   Zink, Wolfgang ^a   Ried, Michael ^a   Schmid, Christof ^a   Diez, Claudius ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Implantable cardioverter defibrillator; Intraoperative test

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION THRESHOLD; FEMALE; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; SHOCK; T WAVE; TREATMENT INDICATION;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTRIC STIMULATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MATERIALS TESTING; MIDDLE AGED; PATIENT SAFETY; STROKE VOLUME; YOUNG ADULT;

EID: 84874310792     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs479     Document Type: Article

References (24)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303:322-4.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
3. Strickberger SA, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 2004;44:88-91.
4. Ideker RE, Epstein AE, Plump VJ. Should shocks still be administered during impantable cardioverter-defibrillator insertion? Heart Rhythm 2005;2:462-3.
5. Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK et al.; SCD-HeFT Investigators. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008;52:551-6.
6. Calvi V, Dugo D, Capodanno D, Arancio R, Di Grazia A, Liotta C et al. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it? Am Heart J 2010;159:98-102.
7. Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P et al. Inductionless or limited shock testing is possible in most patients with implantable cardioverter-defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (arrhythmia single shock defibrillation threshold testing versus upper limit of vulnerability: Risk reduction evaluation with implantable cardioverterdefibrillator implantations). Circulation 2007;115:2382-9.
8. Higgins S, Mann D, Calkins H, Estes NA, Strickberger SA, Breiter D et al. One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: an analysis from the Low Energy Safety Study (LESS). Heart Rhythm 2005;2:117-22.
9. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005;28:926-32.
10. Christ C, Becker R, Voss F, Kelemen K, Senges-Becker J, Hauck M et al. Indications for premissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator. Clin Res Cardiol 2007;96:613-20.
11. Schuger C, Ellenbogen K, Faddis M, Knight BP, Yong P, Sample R. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006;17: 247-50.
12. Joglar JA, Kessler DJ, Welch PJ, Keffer JH, Jessen ME, Hamdan MH et al. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 1999;83:270-72.
13. Mann DE, Klein RC, Higgins SL, Freedmann RA, Hahn SJ, Huang ZZ. The Low Energy Safety Study (LESS): rationale, design, patient characteristics, and device utilization. Am Heart J 2002;143:199-204.
14. Viskin S, Rosse R. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 2008;5:391-3.
15. Taneja T, Goldberger J, Johnson D, Kadish A. Is all ventricular fibrillation the same? Influence of mode of induction on characteristics of ventricular fibrillation. J Cardiovasc Electrophysiol 2000;11:1355-63.
16. Lever NA, Newall EG, Larsen PD. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 2007;9:1054-8.
17. Mäkikallio TH, Huikuri HV, Myerburg RJ, Seppänen T, Kloosterman M, Interian A Jr et al. Differences in the activation patterns between sustained and self-terminating episodes of human ventricular fibrillation. Ann Med 2002;34:130-5.
18. Zima E, Gergerly M, Soós P, Gellér LA, Nemes A, Acsády G et al. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length. J Cardiovasc Electrophysiol 2006;17:377-81.
19. Atary JZ, Borleffs CJ, van der Bom JG, Trines SA, Bootsma M, Zeppenfeld K et al. Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease. Europace 2010;12:1581-8.
20. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 2008;5:391-3.
21. Healey JS, Birnie DH, Lee DS, Krahn AD, Crystal E, Simpson CS et al. Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD registry. J Cardiovasc Electrophysiol 2010;21:1344-8.
22. Goldberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S et al. Long-term benefit of primary prevention with an implantable cardioverterdefibrillator: an extended 8-year follow-up study of the multicenter automatic defibrillator implantation trial II. Circulation 2010;122:1265-71.
23. Parkash R, Sapp JL, Basa M, Doucette S, Thompson K, Gardner M et al. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with significant survival benefit. Circ Arrhythm Electrophysiol 2012;5:706-13.
24. Napp A, Birkenhauer F, Lee KM, Gemein C, Zink M, Knackstedt C et al. ICD-test: is the evaluation of the defibrillation threshold (DFT) still up to date? The ATLANTIS Register. Eur Heart J 2010;31:928-9.